Petra Pharma is based in New York, NY. It has raised $48M in total funding. Latest round: Series A.
Petra Pharma is based in New York, NY. Petra Pharma has raised $48M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2015. The round record for Petra Pharma runs through 2015; nothing later has been disclosed. Investors on record include AbbVie, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, 180 Degree Capital Corp., Empire State Development's Innovate NY Fund and 5 others. 11 distinct backers are named across the disclosed rounds.
Petra Pharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026